Eric Hughes, CPESN® Arkansas Managing Network Facilitator, describes one of three new RxE2 clinical trial recruitment recruitment opportunities for 2023. In this multi-state recruitment, pharamcies in several networks review prescribing records to identify patients with treatment-resistent depression. Some patients with a specific gene marker may participate in an investigational drug study. It's a payable opportunity for patients, and creates network revenue as well.
